Simponi Aria (golimumab) has a half-life of about 14 days in patients with rheumatoid arthritis, meaning it takes roughly 10 to 12 weeks after your last infusion for the drug to be effectively cleared from your body. In healthy subjects, the half-life is slightly shorter at around 12 days. These timelines matter if you’re planning surgery, switching medications, considering pregnancy, or simply wondering how long the drug’s effects linger after you stop treatment.
How Half-Life Translates to Full Clearance
A drug’s half-life is the time it takes for your body to eliminate half of the medication from your bloodstream. For Simponi Aria, that’s approximately 14 days (plus or minus 4 days) in people with rheumatoid arthritis. After one half-life, half remains. After two half-lives, a quarter remains. Pharmacologists generally consider a drug functionally cleared after about five half-lives, when less than 3% of the original dose is still circulating.
For Simponi Aria, five half-lives works out to roughly 10 to 12 weeks, or about 2.5 to 3 months after your final infusion. That said, this is an estimate based on averages. Some people will clear the drug a bit faster, others slower, depending on individual factors like body weight, disease activity, and whether their immune system has developed antibodies against the medication.
What Steady State Means for You
If you’ve been receiving Simponi Aria on the standard schedule (infusions at weeks 0, 4, and then every 8 weeks), your body reaches steady-state drug levels by around week 12. At steady state, each new infusion is topping off a baseline level that’s already in your system rather than building from scratch. This means that when you stop after months or years of treatment, you’re clearing from a higher accumulated baseline than someone who received only a single infusion. The clearance timeline of 10 to 12 weeks still applies, but it starts from that higher steady-state concentration.
Surgery and Timing Your Last Infusion
If you’re planning an elective surgery, the practical question is how far in advance to pause your infusions. Current rheumatology guidelines, including recommendations from the German Society for Rheumatology, suggest pausing for one dosing interval before major surgery. For Simponi Aria, that means skipping the infusion that falls within 8 weeks of your procedure, so your surgery lands at the end of a normal dosing cycle. This approach balances infection risk with the need to keep your underlying condition controlled. Your rheumatologist and surgeon will coordinate this timing based on the complexity of the procedure and your personal risk factors.
How Long Immune Effects Last
Simponi Aria works by blocking a key inflammatory signaling molecule called TNF-alpha. While the drug is in your system, your immune defenses against certain infections are reduced. The FDA labeling advises monitoring for signs of infection both during treatment and after stopping, without specifying an exact cutoff. For certain concerns like hepatitis B reactivation, monitoring should continue for “several months” after the last dose. As a practical rule, the immune-suppressing effects track closely with the drug’s presence in your blood, so you can expect some degree of immunosuppression for roughly that 10 to 12 week clearance window.
Pregnancy and Newborn Exposure
Golimumab crosses the placenta. It has been detected in fetal blood as early as the end of the second trimester and can remain in a newborn’s system for up to 6 months after birth. Because of this prolonged presence, live vaccines (such as rotavirus) are not recommended for infants exposed to Simponi Aria in the womb until at least 6 months after the mother’s last infusion. If you’re pregnant or planning to become pregnant, this extended timeline in newborns is an important consideration for your baby’s vaccination schedule.
Simponi Aria vs. Simponi (Subcutaneous)
Both Simponi Aria (IV) and standard Simponi (subcutaneous injection) contain the same active ingredient, golimumab, and share a similar half-life of about two weeks. The key difference is dosing frequency: Simponi Aria is given every 8 weeks by infusion, while the subcutaneous version is injected every 4 weeks. Because the dosing schedules differ, the steady-state levels and the total amount of drug in your system at any given time will vary between the two formulations, but the basic clearance timeline after your last dose is comparable for both.